Table 1.
Patient I | Patient II.A | Patient II.B | ||||
---|---|---|---|---|---|---|
Age (years) | 9 | 14 | 19 | |||
CD4+ T cells | Ref. Range | Ref. Range | Ref. Range | |||
CD4+ cells/microliter | 590 | 650–1,500 | 340 | 530–1,300 | 284 | 530–1,300 |
CD4+CD45RA+ naïve T cells (%) | 33 | 46–77 | 39 | 33–66 | 27 | 33–66 |
CD4+CD45RO+ memory T cells (%) | 60 | 13–30 | 59 | 18–38 | 72 | 18–38 |
CD4+HLA-DR+ activated T cells (%) | 21 | 3–13 | ||||
CD8+ T Cells | ||||||
CD8+ cells/microliter | 1,728 | 370–1,000 | 175 | 330–920 | 518 | 330–920 |
CD8+CD45RA+ naïve T cells (%) | 65 | 63–92 | 66 | 61–91 | 54 | 61–91 |
CD8+CD45RO+ memory T cells (%) | 24 | 4–21 | 29 | 4–23 | 35 | 4–23 |
CD8+HLA-DR+ activated T cells (%) | 17 | 6–29 | ||||
B Cells | ||||||
CD19+ cells/microliter | 69 | 300–600 | 410 | 200–600 | 136 | 100–600 |
CD27+ memory B cells (%) | 6 | 18.6–46.7 | 3.3 | 13.3–47.9 | 1.5 | 17.5–46.5 |
CD38+IgM+ transitional B cells (%) | 74 | 4.6–8.3 | ||||
CD21low immature B cells (%) | 12.3 | 5.9–25.8 | 58.5 | 2.9–13.2 | 15.4 | 3.2–19.6 |
Immunoglobulins | ||||||
IgM (mg/dL) | 1,230 | 53–334 | 199 | 40–140 | 320 | 44–277 |
Total IgG (mg/dL) | 486 | 613–1,295 | 1,550 | 650–1,500 | 1,410 | 726–1,521 |
IgA (mg/dL) | 9 | 69–309 | 143 | 60–310 | 214 | 87–426 |